Alnylam Pharmaceuticals
ALNY
#596
Rank
$31.63 B
Marketcap
$244.42
Share price
-6.77%
Change (1 day)
62.05%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company